Report cover image

Global Heparin Sodium Injection Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 195 Pages
SKU # APRC20553122

Description

Summary

According to APO Research, The global Heparin Sodium Injection market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Heparin Sodium Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Heparin Sodium Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Heparin Sodium Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Heparin Sodium Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Heparin Sodium Injection include Sichuan Deebio, Shenzhen Hepalink, Nanjing King-friend, Pfizer, Changzhou Qianhong Bio-pharma, Baxter, Yino Pharma Limited, Xinbai Pharmaceuticals and Pharma Action, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Heparin Sodium Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Heparin Sodium Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Heparin Sodium Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Heparin Sodium Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Heparin Sodium Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Heparin Sodium Injection sales, projected growth trends, production technology, application and end-user industry.

Heparin Sodium Injection Segment by Company

Sichuan Deebio
Shenzhen Hepalink
Nanjing King-friend
Pfizer
Changzhou Qianhong Bio-pharma
Baxter
Yino Pharma Limited
Xinbai Pharmaceuticals
Pharma Action
Opocrin
Dongying Tiandong Pharmaceutical
Dongcheng Biochemicals
Changshan Biochemical
Bioibérica
Aspen Oss
Heparin Sodium Injection Segment by Type

1, 000 USP Units / mL
5, 000 USP Units / mL
10, 000 USP Units / mL
Heparin Sodium Injection Segment by Application

Cardioversion of Atrial Fibrillation/Flutter
Complications of Pregnancy
Treatment of Venous Thromboembolism
Other
Heparin Sodium Injection Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin Sodium Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Heparin Sodium Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin Sodium Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Heparin Sodium Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Heparin Sodium Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Heparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Heparin Sodium Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Heparin Sodium Injection Market Size, 2020 VS 2024 VS 2031
1.3 Global Heparin Sodium Injection Market Size Estimates and Forecasts (2020-2031)
1.4 Global Heparin Sodium Injection Sales Estimates and Forecasts (2020-2031)
1.5 Global Heparin Sodium Injection Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Heparin Sodium Injection Market Dynamics
2.1 Heparin Sodium Injection Industry Trends
2.2 Heparin Sodium Injection Industry Drivers
2.3 Heparin Sodium Injection Industry Opportunities and Challenges
2.4 Heparin Sodium Injection Industry Restraints
3 Heparin Sodium Injection Market by Manufacturers
3.1 Global Heparin Sodium Injection Revenue by Manufacturers (2020-2025)
3.2 Global Heparin Sodium Injection Sales by Manufacturers (2020-2025)
3.3 Global Heparin Sodium Injection Average Sales Price by Manufacturers (2020-2025)
3.4 Global Heparin Sodium Injection Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Heparin Sodium Injection Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Heparin Sodium Injection Manufacturers, Product Type & Application
3.7 Global Heparin Sodium Injection Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Heparin Sodium Injection Market CR5 and HHI
3.8.2 Global Top 5 and 10 Heparin Sodium Injection Players Market Share by Revenue in 2024
3.8.3 2024 Heparin Sodium Injection Tier 1, Tier 2, and Tier 3
4 Heparin Sodium Injection Market by Type
4.1 Heparin Sodium Injection Type Introduction
4.1.1 1, 000 USP Units / mL
4.1.2 5, 000 USP Units / mL
4.1.3 10, 000 USP Units / mL
4.2 Global Heparin Sodium Injection Sales by Type
4.2.1 Global Heparin Sodium Injection Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Heparin Sodium Injection Sales by Type (2020-2031)
4.2.3 Global Heparin Sodium Injection Sales Market Share by Type (2020-2031)
4.3 Global Heparin Sodium Injection Revenue by Type
4.3.1 Global Heparin Sodium Injection Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Heparin Sodium Injection Revenue by Type (2020-2031)
4.3.3 Global Heparin Sodium Injection Revenue Market Share by Type (2020-2031)
5 Heparin Sodium Injection Market by Application
5.1 Heparin Sodium Injection Application Introduction
5.1.1 Cardioversion of Atrial Fibrillation/Flutter
5.1.2 Complications of Pregnancy
5.1.3 Treatment of Venous Thromboembolism
5.1.4 Other
5.2 Global Heparin Sodium Injection Sales by Application
5.2.1 Global Heparin Sodium Injection Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Heparin Sodium Injection Sales by Application (2020-2031)
5.2.3 Global Heparin Sodium Injection Sales Market Share by Application (2020-2031)
5.3 Global Heparin Sodium Injection Revenue by Application
5.3.1 Global Heparin Sodium Injection Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Heparin Sodium Injection Revenue by Application (2020-2031)
5.3.3 Global Heparin Sodium Injection Revenue Market Share by Application (2020-2031)
6 Global Heparin Sodium Injection Sales by Region
6.1 Global Heparin Sodium Injection Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Heparin Sodium Injection Sales by Region (2020-2031)
6.2.1 Global Heparin Sodium Injection Sales by Region (2020-2025)
6.2.2 Global Heparin Sodium Injection Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Heparin Sodium Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Heparin Sodium Injection Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Heparin Sodium Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Heparin Sodium Injection Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Heparin Sodium Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Heparin Sodium Injection Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Heparin Sodium Injection Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Heparin Sodium Injection Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Heparin Sodium Injection Revenue by Region
7.1 Global Heparin Sodium Injection Revenue by Region
7.1.1 Global Heparin Sodium Injection Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Heparin Sodium Injection Revenue by Region (2020-2025)
7.1.3 Global Heparin Sodium Injection Revenue by Region (2026-2031)
7.1.4 Global Heparin Sodium Injection Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Heparin Sodium Injection Revenue (2020-2031)
7.2.2 North America Heparin Sodium Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Heparin Sodium Injection Revenue (2020-2031)
7.3.2 Europe Heparin Sodium Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Heparin Sodium Injection Revenue (2020-2031)
7.4.2 Asia-Pacific Heparin Sodium Injection Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Heparin Sodium Injection Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Heparin Sodium Injection Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Sichuan Deebio
8.1.1 Sichuan Deebio Comapny Information
8.1.2 Sichuan Deebio Business Overview
8.1.3 Sichuan Deebio Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Sichuan Deebio Heparin Sodium Injection Product Portfolio
8.1.5 Sichuan Deebio Recent Developments
8.2 Shenzhen Hepalink
8.2.1 Shenzhen Hepalink Comapny Information
8.2.2 Shenzhen Hepalink Business Overview
8.2.3 Shenzhen Hepalink Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Shenzhen Hepalink Heparin Sodium Injection Product Portfolio
8.2.5 Shenzhen Hepalink Recent Developments
8.3 Nanjing King-friend
8.3.1 Nanjing King-friend Comapny Information
8.3.2 Nanjing King-friend Business Overview
8.3.3 Nanjing King-friend Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Nanjing King-friend Heparin Sodium Injection Product Portfolio
8.3.5 Nanjing King-friend Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Heparin Sodium Injection Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Changzhou Qianhong Bio-pharma
8.5.1 Changzhou Qianhong Bio-pharma Comapny Information
8.5.2 Changzhou Qianhong Bio-pharma Business Overview
8.5.3 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Changzhou Qianhong Bio-pharma Heparin Sodium Injection Product Portfolio
8.5.5 Changzhou Qianhong Bio-pharma Recent Developments
8.6 Baxter
8.6.1 Baxter Comapny Information
8.6.2 Baxter Business Overview
8.6.3 Baxter Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Baxter Heparin Sodium Injection Product Portfolio
8.6.5 Baxter Recent Developments
8.7 Yino Pharma Limited
8.7.1 Yino Pharma Limited Comapny Information
8.7.2 Yino Pharma Limited Business Overview
8.7.3 Yino Pharma Limited Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Yino Pharma Limited Heparin Sodium Injection Product Portfolio
8.7.5 Yino Pharma Limited Recent Developments
8.8 Xinbai Pharmaceuticals
8.8.1 Xinbai Pharmaceuticals Comapny Information
8.8.2 Xinbai Pharmaceuticals Business Overview
8.8.3 Xinbai Pharmaceuticals Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Xinbai Pharmaceuticals Heparin Sodium Injection Product Portfolio
8.8.5 Xinbai Pharmaceuticals Recent Developments
8.9 Pharma Action
8.9.1 Pharma Action Comapny Information
8.9.2 Pharma Action Business Overview
8.9.3 Pharma Action Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Pharma Action Heparin Sodium Injection Product Portfolio
8.9.5 Pharma Action Recent Developments
8.10 Opocrin
8.10.1 Opocrin Comapny Information
8.10.2 Opocrin Business Overview
8.10.3 Opocrin Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Opocrin Heparin Sodium Injection Product Portfolio
8.10.5 Opocrin Recent Developments
8.11 Dongying Tiandong Pharmaceutical
8.11.1 Dongying Tiandong Pharmaceutical Comapny Information
8.11.2 Dongying Tiandong Pharmaceutical Business Overview
8.11.3 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Dongying Tiandong Pharmaceutical Heparin Sodium Injection Product Portfolio
8.11.5 Dongying Tiandong Pharmaceutical Recent Developments
8.12 Dongcheng Biochemicals
8.12.1 Dongcheng Biochemicals Comapny Information
8.12.2 Dongcheng Biochemicals Business Overview
8.12.3 Dongcheng Biochemicals Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Dongcheng Biochemicals Heparin Sodium Injection Product Portfolio
8.12.5 Dongcheng Biochemicals Recent Developments
8.13 Changshan Biochemical
8.13.1 Changshan Biochemical Comapny Information
8.13.2 Changshan Biochemical Business Overview
8.13.3 Changshan Biochemical Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.13.4 Changshan Biochemical Heparin Sodium Injection Product Portfolio
8.13.5 Changshan Biochemical Recent Developments
8.14 Bioibérica
8.14.1 Bioibérica Comapny Information
8.14.2 Bioibérica Business Overview
8.14.3 Bioibérica Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.14.4 Bioibérica Heparin Sodium Injection Product Portfolio
8.14.5 Bioibérica Recent Developments
8.15 Aspen Oss
8.15.1 Aspen Oss Comapny Information
8.15.2 Aspen Oss Business Overview
8.15.3 Aspen Oss Heparin Sodium Injection Sales, Price, Revenue and Gross Margin (2020-2025)
8.15.4 Aspen Oss Heparin Sodium Injection Product Portfolio
8.15.5 Aspen Oss Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Heparin Sodium Injection Value Chain Analysis
9.1.1 Heparin Sodium Injection Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Heparin Sodium Injection Production Mode & Process
9.2 Heparin Sodium Injection Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Heparin Sodium Injection Distributors
9.2.3 Heparin Sodium Injection Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.